Genetic Analysis AS vs Thermo Fisher Scientific: Fair Value & Quality
Both stocks run through our valuation models. Here is how Genetic Analysis AS (GEAN) and Thermo Fisher Scientific (TMO) compare, as of Aug 11, 2026.
As of Aug 11, 2026, Fair Value Calculator sees Thermo Fisher Scientific as the less overvalued of the two: Genetic Analysis AS trades at SEK 0.68 versus a fair value of SEK 0.07 (-90%), while Thermo Fisher Scientific trades at $594 versus $308 (-48%).
Genetic Analysis AS
GEAN.ST · SEK · Healthcare
-90%
upside to fair value
overvalued
PriceSEK 0.68
Fair ValueSEK 0.07
Quality33/100
Thermo Fisher Scientific
TMO · USD · Health Care
-48%
upside to fair value
overvalued
Price$594
Fair Value$308
Quality63/100
Head-to-head numbers
Green value = the better side for that row (for valuation multiples: lower = cheaper).
Genetic Analysis ASThermo Fisher Scientific
Valuation
—P/E (TTM)29.5×
0.22×P/S (TTM)4.41×
0.18×P/B3.74×
—EV/EBITDA20.0×
—PEG1.74×
—Dividend yield0.3%
—Dividend per share$1.76
Profitability
-53%Net margin15%
-101%Operating margin18%
-56%Return on equity14%
-16%Return on assets5%
Growth
9%Revenue growth (YoY)6%
14.4%Avg. growth/yr (3Y)-0.3%
23.7%Avg. growth/yr (5Y)6.7%
Balance & size
0.15×Debt / equity0.67×
$5MMarket cap$199B
expensiveGrowth qualityhealthy
Genetic Analysis AS leads: 6 to 4 metric wins.
Dash = not meaningfully computable, for example with negative equity.
Quality in detail
The quality score, broken down into the same factor families as on the stock page, 0 to 100 per family.
Genetic Analysis ASof which business quality 33 · market factors 21Thermo Fisher Scientificof which business quality 60 · market factors 65
ProfitabilityMargins and returns on capital today
11
43
Quality GrowthAre margins and returns improving?
39
31
CashflowEarnings quality: real cash, not paper profit
InvestmentDisciplined investing over empire-building
67
79
Low VolatilityCalm price path (market factor)
0
68
MomentumPrice trend over the last 3–12 months (market factor)
36
58
52W MomentumDistance to the 52-week high (market factor)
19
72
Net IssuanceBuybacks instead of dilution
0
97
What the models say
The median fair value (base case) per model family, each in the currency of its trading venue. Green = above the current price, red = below.
Genetic Analysis AS
Asset-BasedSEK 0.26
1 of 1 models see the stock below the current price.
Thermo Fisher Scientific
DCF Models$354
Earnings-Based$203
Multiples$308
Asset-Based$96.29
Growth DCF$288
Economic Profit$159
Growth Earnings$341
24 of 24 models see the stock below the current price.
Scenario ranges
From our cautious bear case to the optimistic bull case. The white tick is the current price: left of fair value means room to run.
Genetic Analysis AS
Bear SEK 0.04Fair Value SEK 0.07Bull SEK 0.09
SEK 0.68 = current price (white tick)
Thermo Fisher Scientific
Bear $175Fair Value $308Bull $385
$594 = current price (white tick)
Compare two other stocks
Tap a field and type again, ticker or company name.
Free, no sign-up
Ranked within their sector
Where each stock sits within its sector peer group. Band = middle 50% of peers, tick = median, dot = this stock.
Genetic Analysis AS · Healthcare
Quality score33 · bottom 25%
Fair value upside-90% · bottom 25%
Thermo Fisher Scientific · Health Care
Quality score63 · above median
Fair value upside-48% · below median
Bottom line
As of Aug 11, 2026, Fair Value Calculator sees Thermo Fisher Scientific as the less overvalued of the two: Genetic Analysis AS trades at SEK 0.68 versus a fair value of SEK 0.07 (-90%), while Thermo Fisher Scientific trades at $594 versus $308 (-48%).
Thermo Fisher Scientific has the higher quality score (63/100).
Just your email for the monthly Top-25 report of the most undervalued quality stocks, with fair value, quality and price target. Plus 14 days of Pro to try, no card.
Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click. Not financial advice.
A model-based valuation snapshot from 21 models. Values change with price and fundamentals; the date shown above applies.
